Ortho Surgeons Remain Split On Benefits Of MIS For Knees
This article was originally published in The Gray Sheet
Executive Summary
Arthroscopy manufacturers' push for minimally invasive knee surgery could lead to higher long-term complication rates, knee surgeons contended at the annual meeting of the American Academy of Orthopedic Surgeons
You may also be interested in...
Zimmer Integration Effort “Ahead Of Schedule,” Will Cost $79 Mil. In 2004
Zimmer hopes to further differentiate its total knee replacement offerings with the formal launch of its MIS Quad-Sparing minimally-invasive implant procedure at the American Academy of Orthopedic Surgeons meeting March 10-14 in San Francisco
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.